Skip to main content
. 2021 Jul 22;12:679897. doi: 10.3389/fimmu.2021.679897

Figure 9.

Figure 9

Kae exerts excellent anti-UC effects via gut microbiota pathways related to the LPS-TLR4-NF-κB core pathway. Kae reduces LPS levels by inhibiting the proliferation of pathogenic Gram-negative bacilli, thereby altering the metabolic profile, blocking NF-κB pathway activation, improving intestinal tight junction integrity, inhibiting pro-inflammatory factors, and increasing antioxidants, thus decreasing DSS-induced colonic inflammation.